昂利康：获得美索巴莫注射液药品注册证书

Core Viewpoint - The company, Anglikang (002940), has received a drug registration certificate from the National Medical Products Administration for Mesobam Injection, which is intended for the treatment of acute skeletal muscle pain or discomfort [1] Group 1: Product Information - Mesobam Injection is classified as a Class 3 chemical drug with a specification of 10ml:1g [1] - The approval of the drug registration certificate will enhance the company's product pipeline [1] Group 2: Market Considerations - The sales performance of Mesobam Injection may be influenced by national policies and changes in the market environment, indicating a significant level of uncertainty [1]